Patents by Inventor Fabian Jameison

Fabian Jameison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9505619
    Abstract: Graphitic nanotubes, which include tubular fullerenes (commonly called “buckytubes”) and fibrils, which are functionalized by chemical substitution, are used as solid supports in electrogenerated chemiluminescence assays. The graphitic nanotubes are chemically modified with functional group biomolecules prior to use in an assay. Association of electrochemiluminescent ruthenium complexes with the functional group biomolecule-modified nanotubes permits detection of molecules including nucleic acids, antigens, enzymes, and enzyme substrates by multiple formats.
    Type: Grant
    Filed: March 20, 2006
    Date of Patent: November 29, 2016
    Assignee: MESO SCALE TECHNOLOGIES, LLC.
    Inventors: Richard J. Massey, Mark T. Martin, Liwen Dong, Ming Lu, Alan Fischer, Fabian Jameison, Pam Liang, Robert Hoch, Jonathan K. Leland
  • Publication number: 20060160246
    Abstract: Graphitic nanotubes, which include tubular fullerenes (commonly called “buckytubes”) and fibrils, which are functionalized by chemical substitution, are used as solid supports in electrogenerated chemiluminescence assays. The graphitic nanotubes are chemically modified with functional group biomolecules prior to use in an assay. Association of electrochemiluminescent ruthenium complexes with the functional group biomolecule-modified nanotubes permits detection of molecules including nucleic acids, antigens, enzymes, and enzyme substrates by multiple formats.
    Type: Application
    Filed: March 20, 2006
    Publication date: July 20, 2006
    Inventors: Richard Massey, Mark Martin, Liwen Dong, Ming Lu, Alan Fischer, Fabian Jameison, Pam Liang, Robert Hoch, Jonathan Leland
  • Patent number: 7052861
    Abstract: Graphitic nanotubes, which include tubular fullerenes (commonly called “buckytubes”) and fibrils, which are functionalized by chemical substitution, are used as solid supports in electrogenerated chemiluminescence assays. The graphitic nanotubes are chemically modified with functional group biomolecules prior to use in an assay. Association of electrochemiluminescent ruthenium complexes with the functional group biomolecule-modified nanotubes permits detection of molecules including nucleic acids, antigens, enzymes, and enzyme substrates by multiple formats.
    Type: Grant
    Filed: December 5, 2001
    Date of Patent: May 30, 2006
    Assignee: Meso Scale Technologies, LLC.
    Inventors: Richard J. Massey, Mark T. Martin, Liwen Dong, Ming Lu, Alan Fischer, Fabian Jameison, Pam Liang, Robert Hoch, Jonathan K. Leland
  • Publication number: 20040202603
    Abstract: Graphitic nanotubes, which includes tubular fullerenes (commonly called “buckytubes”) and fibrils, which are functionalized by chemical substitution or by adsorption of functional moieties. More specifically the invention relates to graphitic nanotubes which are uniformly or non-uniformly substituted with chemical moieties or upon which certain cyclic compounds are adsorbed and to complex structures comprised of such functionalized nanotubes linked to one another. The invention also relates to methods for introducing functional groups onto the surface of such nanotubes. The invention further relates to uses for functionalized nanotubes.
    Type: Application
    Filed: April 30, 2004
    Publication date: October 14, 2004
    Applicant: Hyperion Catalysis International, Inc.
    Inventors: Alan Fischer, Robert Hoch, David Moy, Ming Lu, Mark Martin, Chun Ming Niu, Naoya Ogata, Howard Tennent, Liwen Dong, Ji Sun, Larry Helms, Fabian Jameison, Pam Liang, David Simpson
  • Publication number: 20020086335
    Abstract: Graphitic nanotubes, which include tubular fullerenes (commonly called “buckytubes”) and fibrils, which are functionalized by chemical substitution, are used as solid supports in electrogenerated chemiluminescence assays. The graphitic nanotubes are chemically modified with functional group biomolecules prior to use in an assay. Association of electrochemiluminescent ruthenium complexes with the functional group biomolecule-modified nanotubes permits detection of molecules including nucleic acids, antigens, enzymes, and enzyme substrates by multiple formats.
    Type: Application
    Filed: December 5, 2001
    Publication date: July 4, 2002
    Applicant: Meso Scale Technology LLP
    Inventors: Richard J. Massey, Mark T. Martin, Liwen Dong, Ming Lu, Alan Fischer, Fabian Jameison, Pam Liang, Robert Hoch, Jonathan K. Leland
  • Patent number: 6362011
    Abstract: Graphitic nanotubes, which include tubular fullerenes (commonly called “buckytubes”) and fibrils, which are functionalized by chemical substitution, are used as solid supports in electrogenerated chemiluminescence assays. The graphitic nanotubes are chemically modified with functional group biomolecules prior to use in an assay. Association of electrochemiluminescent ruthenium complexes with the functional group biomolecule-modified nanotubes permits detection of molecules including nucleic acids, antigens, enzymes, and enzyme substrates by multiple formats.
    Type: Grant
    Filed: February 2, 1999
    Date of Patent: March 26, 2002
    Assignee: Meso Scale Technologies, LLC
    Inventors: Richard J. Massey, Mark T. Martin, Liwen Dong, Ming Lu, Alan Fischer, Fabian Jameison, Pam Liang, Robert Hoch, Jonathan K. Leland
  • Patent number: 6136233
    Abstract: An electrochemiluminescence (ECL)-based assay for the quantitation of classical clinical chemistry analytes, where glucose, ethanol, carbon dioxide, cholesterol, as H.sub.2 O.sub.2 liberating systems coupled to a tris(bipyridyl)ruthenium(II) Ru(bpy).sub.3.sup.2+ luminophore generate an ECL signal, which can be detected spectrophotometrically or electrochemically. The H.sub.2 O.sub.2 present reacts with oxalate in the presence of Ru(bpy).sub.3.sup.2+ to give an ECL response.
    Type: Grant
    Filed: August 20, 1998
    Date of Patent: October 24, 2000
    Assignee: IGEN International, Inc.
    Inventors: Fabian Jameison, Jonathan K. Leland
  • Patent number: 6099760
    Abstract: An electrochemiluminescence (ECL)-based assay for the quantitation of classical clinical chemistry analytes, where glucose, ethanol, carbon dioxide, cholesterol, as H.sub.2 O.sub.2 liberating systems coupled to a tris(bipyridyl)ruthenium(II) Ru(bpy).sub.3.sup.2+ luminophore generate an ECL signal, which can be detected spectrophotometrically or electrochemically. The H.sub.2 O.sub.2 present reacts with oxalate in the presence of Ru(bpy).sub.3.sup.2+ to give an ECL response.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 8, 2000
    Assignee: IGEN, Inc.
    Inventors: Fabian Jameison, Jonathan K. Leland
  • Patent number: 5866434
    Abstract: Graphitic nanotubes, which include tubular fullerenes (commonly called "buckytubes") and fibrils, which are functionalized by chemical substitution, are used as solid supports in electrogenerated chemiluminescence assays. The graphitic nanotubes are chemically modified with functional group biomolecules prior to use in an assay. Association of electrochemiluminescent ruthenium complexes with the functional group biomolecule-modified nanotubes permits detection of molecules including nucleic acids, antigens, enzymes, and enzyme substrates by multiple formats.
    Type: Grant
    Filed: March 6, 1996
    Date of Patent: February 2, 1999
    Assignee: Meso Scale Technology
    Inventors: Richard J. Massey, Mark T. Martin, Liwen Dong, Ming Lu, Alan Fischer, Fabian Jameison, Pam Liang, Robert Hoch, Jonathan K. Leland